The head of GlaxoSmithKline's pharmaceuticals division is pushing to cut its budget by 20 percent. Source: BioSpace

AstraZeneca’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released today. Source: BioSpace

The FDA granted a Priority Review designation to Pfizer and partner Astellas Pharma for expanded use of Xtandi in prostrate cancer treatment. Source: BioSpace

Gilead Sciences essentially created a cure for hepatitis C and may be well on its way to developing a cure for HIV-AIDS. Source: BioSpace

Arena Pharmaceuticals released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis. Source: BioSpace

Ocugen announced this morning that its mid-stage combination treatment hit its primary endpoint of tolerability in a proof-of-concept trial. Source: BioSpace

Alzheon hopes to raise about $80 million, which will help fund two Phase III clinical trials for its ALZ-801 for Alzheimer’s disease. Source: BioSpace

Heron Therapeutics said its late-stage anesthetic used to treat bunionectomy and hernia repair hit all primary and key secondary endpoints in two Phase III trials that cut down on the…

Denali Therapeutics, located in South San Francisco, California, had a lot of news to share today. Source: BioSpace

Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market…